Abryx Partners with SurgiCor to Expand Distribution of Bone Putty

Abyrx Inc. has partnered with SurgiCor to significantly expand the distribution of its hemostatic bone putty products (AHBP, Hemasorb, Hemasorb Apply, and Hemasorb Plus) to orthopedic and spine surgeries throughout the United States.

Under the terms of the agreement, SurgiCor will have leadership responsibility for representing Abyrx’s products in a regional territory and for aggregating additional orthopedic and spine distributors throughout the country.

Abyrx and SurgiCor will use the Kairuku platform to organize a variable commissioning structure for SurgiCor and its affiliate distribution representatives and to track product utilization at the point-of-care to ensure accurate and timely reporting of sales and compensation.

Abyrx will use Kairuku to seamlessly integrate SurgiCor’s representatives and their affiliate partners into Abyrx’s existing distribution network, which currently comprises several hundred cardiac, craniomaxillofacial, and spine representatives, according to Abryx.

Abyrx will maintain responsibility for its own product training and payment of compensation owed to SurgiCor and its partners.

“The current frictional dynamics that exist for new product launches to hospitals, particularly within the biosurgical products marketplace, required us to rethink the traditional distribution model and create new solutions to enable Abyrx to access and service operating rooms across surgical specialties,” Abyrx President/CEO John J. Pacifico said. “Abyrx’s partnership with SurgiCor and our use of the Kairuku Platform will enable us to quickly aggregate orthopedic and spine distributors throughout the United States and drive widespread adoption of Abyrx’s hemostatic bone putties and pipeline products in millions of surgical procedures performed each year.”

To further support the uptake of AHBP, Hemasorb, Hemasorb Apply, and Hemasorb Plus among surgeons, Abyrx’s professional account liaison team members will continue to use the Kairuku Platform to recruit and partner with leading independent product representatives throughout the United States.

Founded last year in Irvington, N.Y., Abyrx develops, manufactures and provides specialty biosurgical products for use during surgical procedures. The company’s portfolio of U.S. Food and Drug Administration-cleared products includes three putties that stop bone bleeding and three applicator devices.

SurgiCor sells and distributes various orthopedic devices, spinal implants, orthobiologics, and other surgical products. The company is located in Franklin,Tenn.